{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:02:04Z","timestamp":1785178924084,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","burnsjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.burns.2017.10.022","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T11:54:59Z","timestamp":1522842899000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5173-4421","authenticated-orcid":false,"given":"Anthony","family":"Papp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-3024","authenticated-orcid":false,"given":"Morgan","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-0026","authenticated-orcid":false,"given":"Diana","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Miliszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (2)","key":"10.1016\/j.burns.2017.10.022_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.burns.2017.10.022_bib0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exudativum multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis in Germany (1990\u20131992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.burns.2017.10.022_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0190-9622(92)70082-Q","article-title":"Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus","volume":"26","author":"Saiag","year":"1992","journal-title":"J Am Dermatol"},{"issue":"4","key":"10.1016\/j.burns.2017.10.022_bib0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane\u00ae for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients","volume":"34","author":"Boorboor","year":"2008","journal-title":"Burns"},{"issue":"8","key":"10.1016\/j.burns.2017.10.022_bib0025","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bjps.2014.04.003","article-title":"Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm","volume":"67","author":"Abela","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"March\u2013April (2)","key":"10.1016\/j.burns.2017.10.022_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"issue":"1","key":"10.1016\/j.burns.2017.10.022_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2133\/dmpk.DMPK-11-RV-116","article-title":"A recent update of pharmacogenomics in drug-induced severe skin reactions","volume":"27","author":"Wei","year":"2012","journal-title":"DMPK"},{"issue":"3","key":"10.1016\/j.burns.2017.10.022_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Aust J Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2017.10.022_bib0045","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2017.10.022_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.burns.2017.10.022_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2007","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.burns.2017.10.022_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/565320","article-title":"HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review","author":"Cheng","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.burns.2017.10.022_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2014.05.025","volume":"37","author":"Wang","year":"2010","journal-title":"Epilepsy Behavior"},{"key":"10.1016\/j.burns.2017.10.022_bib0070","first-page":"1","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centers","author":"Mahar","year":"2014","journal-title":"Burns"},{"issue":"5","key":"10.1016\/j.burns.2017.10.022_bib0075","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","article-title":"Retrospective review of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine","volume":"71","author":"Kirchhof","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"November (5)","key":"10.1016\/j.burns.2017.10.022_bib0080","article-title":"Treatment of toxic epidermal necrolysis in North America","volume":"73","author":"Dodiuk-Gad","year":"2015","journal-title":"JAAD"},{"issue":"3","key":"10.1016\/j.burns.2017.10.022_bib0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/0970-0358.90826","article-title":"Collagen sheet dressings for cutaneous lesions of toxic epidermal necrolysis","volume":"44","author":"Bhattacharya","year":"2011","journal-title":"Indian J Plast Surg"},{"issue":"12","key":"10.1016\/j.burns.2017.10.022_bib0090","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jpedsurg.2006.08.043","article-title":"Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing","volume":"41","author":"Asz","year":"2006","journal-title":"J Pediatr Surg"},{"issue":"S","key":"10.1016\/j.burns.2017.10.022_bib0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2010.11.046","article-title":"Drug hypersensitivity: pharmacogenetics and clinical syndromes","volume":"127","author":"Phillips","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.burns.2017.10.022_bib0100","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B*1502Allele and carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.burns.2017.10.022_bib0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.burns.2009.02.018","article-title":"Aquacel\u00ae Ag with vaseline gauze in the management of toxic epidermal necrolysis (TEN)","volume":"36","author":"Huang","year":"2010","journal-title":"Burns"},{"issue":"12","key":"10.1016\/j.burns.2017.10.022_bib0110","first-page":"1173","article-title":"Skin allograft in the treatment of toxic epidermal necrolysis (TEN)","volume":"28","author":"Piangini","year":"2002","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.burns.2017.10.022_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000637-199508000-00002","article-title":"Toxic epidermal necrolysis: a review and report of the successful use of Biobrane for early wound coverage","volume":"35","author":"Bradley","year":"1995","journal-title":"Ann Plast Surg"},{"issue":"6","key":"10.1016\/j.burns.2017.10.022_bib0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.burns.2009.04.008","article-title":"Use of Acticoat\u2122 dressings in burns: what is the evidence?","volume":"36","author":"Khundkar","year":"2010","journal-title":"Burns"},{"key":"10.1016\/j.burns.2017.10.022_bib0125","first-page":"1","article-title":"Secondary bacterial infection and empirical antibiotic use in toxic epidermal necrolysis patients","author":"Mahar","year":"2014","journal-title":"J Burn Care Res"},{"issue":"3","key":"10.1016\/j.burns.2017.10.022_bib0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/BCR.0B013E318053D3A1","article-title":"The phenomenon of fluid creep in acute burn resuscitation","volume":"28","author":"Saffle","year":"2007","journal-title":"J Burn Care Res"},{"issue":"9","key":"10.1016\/j.burns.2017.10.022_bib0135","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archderm.1987.01660330077013","article-title":"The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell\u2019s syndrome)","volume":"123","author":"Guillaume","year":"1987","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2017.10.022_bib0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2133.2012.11032.x","article-title":"IVIg in TEN: time to re-evaluate the efficacy of intravenous immunoglobulin in the management of toxic epidermal necrolysis","volume":"167","author":"Walsh","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.burns.2017.10.022_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/237821","article-title":"Retrospective analysis of corticosteroid treatment in Stevens\u2013Johnson syndrome and\/or toxic epidermal necrolysis over a period of 10 years in Vajira Hospital, Navamindradhiraj University, Bangkok","volume":"2014","author":"Roongpisuthipong","year":"2014","journal-title":"Dermatol Res Pract"},{"issue":"2","key":"10.1016\/j.burns.2017.10.022_bib0150","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.burns.2017.10.022_bib0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BCR.0b013e318283d18c","article-title":"Use of therapeutic plasma exchange in the burn unit","volume":"34","author":"Mosier","year":"2013","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2017.10.022_bib0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","article-title":"Etanercept therapy for toxic epidermal necrolysis","volume":"71","author":"Paradisi","year":"2014","journal-title":"J Am Dermatol"},{"issue":"8","key":"10.1016\/j.burns.2017.10.022_bib0165","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1445-2197.2007.04184.x","article-title":"Toxic epidermal necrolysis\/Stevens\u2013Johnson syndrome: current trends in management","volume":"77","author":"Dalli","year":"2007","journal-title":"ANZ J Surg"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417917305909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417917305909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T14:28:08Z","timestamp":1534948088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417917305909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0305417917305909"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2017.10.022","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}